Clinical trials on advanced therapy medicinal products should be conducted in accordance with the overarching principles and the ethical requirements laid down in Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use [OJ L 121, 1.5.2001, p. 34. Directive as amended by Regulation (EC) No 1901/2006.]. However, Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products [OJ L 91, 9.4.2005, p. 13.] should be adapted by laying down rules tailored to fully take into account the specific technical characteristics of advanced therapy medicinal products.
Recital 16, Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…
In force
- celex=32006L1901